These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30444134)

  • 61. The relevance of pyroptosis in the pathogenesis of liver diseases.
    Guo H; Xie M; Zhou C; Zheng M
    Life Sci; 2019 Apr; 223():69-73. PubMed ID: 30831126
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Distinctly altered gut microbiota in the progression of liver disease.
    Xie G; Wang X; Liu P; Wei R; Chen W; Rajani C; Hernandez BY; Alegado R; Dong B; Li D; Jia W
    Oncotarget; 2016 Apr; 7(15):19355-66. PubMed ID: 27036035
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation.
    van Best N; Jansen PL; Rensen SS
    Hepatol Int; 2015 Jul; 9(3):406-15. PubMed ID: 26067771
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Probiotics and Liver Disease: Where Are We Now and Where Are We Going?
    Elzouki AN
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S188-S190. PubMed ID: 27741172
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Saccharin induced liver inflammation in mice by altering the gut microbiota and its metabolic functions.
    Bian X; Tu P; Chi L; Gao B; Ru H; Lu K
    Food Chem Toxicol; 2017 Sep; 107(Pt B):530-539. PubMed ID: 28472674
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gut-liver axis: gut microbiota in shaping hepatic innate immunity.
    Wu X; Tian Z
    Sci China Life Sci; 2017 Nov; 60(11):1191-1196. PubMed ID: 28840534
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [1-14C]Ethanol breath test in alcoholic liver disease.
    MacDougall BR; Dordoni B; Thompson RP; Davis M; Williams R
    Clin Chim Acta; 1978 May; 86(1):121-7. PubMed ID: 657531
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
    Kirpich IA; Marsano LS; McClain CJ
    Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Microbiota, a key player in alcoholic liver disease.
    Cassard AM; Ciocan D
    Clin Mol Hepatol; 2018 Jun; 24(2):100-107. PubMed ID: 29268595
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease.
    Dubinkina VB; Tyakht AV; Odintsova VY; Yarygin KS; Kovarsky BA; Pavlenko AV; Ischenko DS; Popenko AS; Alexeev DG; Taraskina AY; Nasyrova RF; Krupitsky EM; Shalikiani NV; Bakulin IG; Shcherbakov PL; Skorodumova LO; Larin AK; Kostryukova ES; Abdulkhakov RA; Abdulkhakov SR; Malanin SY; Ismagilova RK; Grigoryeva TV; Ilina EN; Govorun VM
    Microbiome; 2017 Oct; 5(1):141. PubMed ID: 29041989
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Last Hurrah.
    Berk PD
    Semin Liver Dis; 2016 Sep; 36(4):297-298. PubMed ID: 27997967
    [No Abstract]   [Full Text] [Related]  

  • 72. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.
    Federico A; Dallio M; Loguercio C
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28125040
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [CHANGES IN MICROBIOCENOSIS OF THE COLON IN PATIENTS WITH CHRONIC LIVER DISEASE AND LATENT HEPATIC ENCEPHALOPATHY].
    Teterina LA; Curcumia DB; Seliverstov PV; Radchenko VG
    Eksp Klin Gastroenterol; 2015; (11):38-44. PubMed ID: 27214986
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.
    Pereira-Fantini PM; Lapthorne S; Joyce SA; Dellios NL; Wilson G; Fouhy F; Thomas SL; Scurr M; Hill C; Gahan CG; Cotter PD; Fuller PJ; Hardikar W; Bines JE
    J Hepatol; 2014 Nov; 61(5):1115-25. PubMed ID: 24999016
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Specific features of the enteric microbiota composition in patients with alcoholic liver cirrhosis].
    Shalikiani NV; Bakulin IG; Dubinkina VB; Ishchenko DS; Alexeev DG; Tyakht AV; Pavlenko AV; Ilyina EN; Kostryukova ES; Taraskina AE; Skorodumova LO; Maev IV; Govorun VM
    Ter Arkh; 2015; 87(12):59-65. PubMed ID: 26978420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of polysaccharide from Physalis alkekengi var. francheti on liver injury and intestinal microflora in type-2 diabetic mice.
    Zhao X; Chen Z; Yin Y; Li X
    Pharm Biol; 2017 Dec; 55(1):2020-2025. PubMed ID: 28832229
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.
    Liu JP; Zou WL; Chen SJ; Wei HY; Yin YN; Zou YY; Lu FG
    World J Gastroenterol; 2016 Aug; 22(32):7353-64. PubMed ID: 27621581
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of the intestinal microbiome in liver disease.
    Henao-Mejia J; Elinav E; Thaiss CA; Licona-Limon P; Flavell RA
    J Autoimmun; 2013 Oct; 46():66-73. PubMed ID: 24075647
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial.
    Madsen BS; Trebicka J; Thiele M; Israelsen M; Arumugan M; Havelund T; Krag A
    Trials; 2018 Feb; 19(1):143. PubMed ID: 29482588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.